Autres langues VolitionRx Limited

Actions

VNRX

US9286611077

Marché Fermé - Nyse Autres places de cotation 22:00:00 03/05/2024			Varia. 5j.	Varia. 1 janv.
0,8909 ^USD	+1,43 %		-2,50 %	+24,25 %

26/04	VolitionRx Limited annonce des changements au sein de son conseil d'administration	CI
23/04	VolitionRx Limited lance son test en clinique aux États-Unis et en Europe par l'intermédiaire d'Antech	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

VolitionRx Limited Announces Board Changes	26/04
VolitionRx Limited Launches In-Clinic in U.S. and Europe Through Antech	23/04
VolitionRx Limited announced that it has received $0.1 million in funding	26/03
VolitionRx Limited Reports Earnings Results for the Full Year Ended December 31, 2023	25/03
North American Morning Briefing : Tech in Focus on -2-	25/03
VolitionRx Limited Agrees Supply Agreement with Fujifilm Vet Systems Co. Ltd	20/03
VolitionRx Names Andrew Retter as Chief Medical Officer	19/03
Volitionrx Limited Appoints Andrew Retter as Chief Medical Officer, Effective April 1, 2024	19/03
VolitionRx Limited announced that it expects to receive $0.1 million in funding	12/03
Sector Update: Health Care Stocks Gain Late Afternoon	02/01
Sector Update: Health Care	02/01
VolitionRX Shares Soar After $13.0 Million Milestone Payments From Heska	02/01
VolitionRx Limited Secures Approximately $5.5 Million in Belgium Regional Government Financing from Wallonie Entreprendre	05/12
VolitionRx Limited announced that it has received ?2.5 million in funding	05/12
VolitionRX: Q3 Earnings Snapshot	15/11
VolitionRx Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
Volition and VPG Launch Nu.Q Vet Cancer Test in UK and Ireland	07/11
VolitionRx Limited and Veterinary Pathology Group joins forces to launch the Nu.Q(R) Vet Cancer Test to veterinary practices in the UK and Ireland	06/11
VolitionRx Limited Presents Breakthrough Liquid Biopsy Blood Test Method for Early-Stage Cancer	23/10/23
Certain Options of VolitionRx Limited are subject to a Lock-Up Agreement Ending on 30-AUG-2023.	30/08/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues VolitionRx Limited

Actions

VNRX

US9286611077

Autres langues

Filtres